Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience

被引：0
|
作者：
Dukovski, Dushko [1 ]
Trajkova, Sanja [1 ]
Stojanovska, Simona [1 ]
Ridova, Nevenka [1 ]
Panovska-Stavridis, Irina [1 ]
机构：
[1] Clin Hematol, Skopje, North Macedonia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
CML; imatinib; selective tyrosine kinase inhibitor (TKI); chronic myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-104
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India
    Phukan, Abhijit
    Mandal, Prakas Kumar
    Dolai, Tuphan K.
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 85 - 96
  • [22] Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital
    Doval, D. C.
    Batra, Ullas
    Goyal, Sumit
    Sharma, Ajay
    Azam, Saud
    Shirali, Rashmi
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (03) : 182 - 185
  • [23] Cytogenetic findings in imatinib mesylate-treated Philadelphia-positive chronic myelogenous leukemia patients: a single-center experience
    Mesanovic, Semir
    Peric, Milan
    Mustedanagic-Mujanovic, Jasminka
    Iljazovic, Ermina
    Cickusic, Elmir
    Eminovic, Izet
    CHROMOSOME RESEARCH, 2011, 19 : S142 - S143
  • [24] Impact of imatinib interruption and duration of prior hydroxyurea on the treatment outcome in patients with chronic myeloid leukemia: Single institution experience
    Edesa, Wael Abdelgawad
    Abdel-malek, Raafat Ragaey
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2015, 27 (02) : 69 - 75
  • [25] Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country
    Medhi, Kunjahari
    Raina, Vinod
    Kumar, Lalit
    Sharma, Atul
    Bakhshi, Sameer
    Gupta, Ritu
    Kumar, Rajive
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1850 - 1854
  • [26] Additional cytogenetic aberrations in chronic myeloid leukemia: a single-center experience in the Middle East
    Safaei, Akbar
    Monabati, Ahmad
    Safavi, Moeinadin
    Atashabparvar, Ali
    Hosseini, Marzieh
    BLOOD RESEARCH, 2018, 53 (01) : 49 - 52
  • [27] Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
    Gemelli, Maria
    Elli, Elena Maria
    Elena, Chiara
    Iurlo, Alessandra
    Intermesoli, Tamara
    Maffioli, Margherita
    Pungolino, Ester
    Carraro, Maria Cristina
    D'Adda, Mariella
    Lunghi, Francesca
    Anghileri, Michela
    Polverelli, Nicola
    Rossi, Marianna
    Bacciocchi, Mattia
    Bono, Elisa
    Bucelli, Cristina
    Passamonti, Francesco
    Antolini, Laura
    Gambacorti-Passerini, Carlo
    BLOOD RESEARCH, 2020, 55 (03) : 139 - 145
  • [28] Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience
    Szczepanek, Elzbieta
    Chukwu, Ositadima
    Kaminska, Magdalena
    Wysoglad, Hubert
    Cenda, Agnieszka
    Zawada, Magdalena
    Jakobczyk, Malgorzata
    Waclaw, Joanna
    Sacha, Tomasz
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2213 - 2223
  • [29] Imatinib Generic in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase: Egyptian National Cancer Institute Experience
    Maher, Mohamed
    Samra, Mohamed
    Abdelfatah, Raafat
    ElGammal, Mosaad
    Kamel, Hossam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S296 - S297
  • [30] Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase
    Moura, Muriel Silva
    Benevides, Thais Celi Lopes
    Delamain, Marcia Torresan
    Duarte, Gislaine Oliveira
    Percout, Priscila Oliveira
    Dias, Maria Almeida
    Zulli, Roberto
    Souza, Carmino Antonio de
    Lorand-Metze, Irene
    Pagnano, Katia Borgia Barbosa
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2019, 41 (04) : 329 - 334
12345